C
INKT icon

Covestor’s MiNK Therapeutics INKT Stock Holding History

Covestor’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
119
– – ﹤0.01% 2197
2026
Q1 		$1K Sell
119
-12
-9% -$134 ﹤0.01% 2060
2025
Q4 		$1K Hold
131
– – ﹤0.01% 2081
2025
Q3 		$2K Hold
131
– – ﹤0.01% 1953
2025
Q2 		$1K Buy
131
+27
+26% +$203 ﹤0.01% 2016
2025
Q1 		$1K Sell
104
-1
-1% -$9 ﹤0.01% 2006
2024
Q4 		$1K Hold
105
– – ﹤0.01% 2058
2024
Q3 		$1K Sell
105
-1
-0.9% -$8 ﹤0.01% 2006
2024
Q2 		$1K Hold
106
– – ﹤0.01% 2024
2024
Q1 		$1K Sell
106
-1
-0.9% -$9 ﹤0.01% 2001
2023
Q4 		$1K Sell
107
-1
-0.9% -$10 ﹤0.01% 1986
2023
Q3 		$1K Buy
108
+50
+86% +$814 ﹤0.01% 1951
2023
Q2 		$1K Buy
+58
New +$1.16K ﹤0.01% 1962

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Covestor's INKT Position: Q2 2026 in Review

Covestor held its MiNK Therapeutics (INKT) position steady in Q2 2026 at 119 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Covestor first reported a position in INKT in Q2 2023 and has held it in 13 quarters since. The position peaked at $2K in Q3 2025. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

  • Covestor held 119 shares of MiNK Therapeutics worth $1K as of Q2 2026.
  • Covestor left its MiNK Therapeutics share count unchanged in Q2 2026.
  • MiNK Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2197 holding.
  • Covestor first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Covestor's MiNK Therapeutics position peaked at $2K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.